| Participating
Companies:
Rutgers University
Johnson & Johnson PRD LLC.
Memorial Sloan-Kettering Institute, Genomics Core Facility
Amgen, Inc.
Columbia University College of Physicians & Surgeons
Russian Academy of Sciences, Moscow, Russia
Amersham Biosciences
Massachusetts General Hospital, Harvard Medical School
New York State Pyschiatric Institute
New England Biolabs
Affymetrix, Inc.
University of Leicester and Leicester Royal Infirmary, Leicester,
United Kingdom
Stratagene
Millennium Pharmaceuticals, Inc.
Mount Sinai School of Medicine
Regeneron Pharmaceuticals, Inc.
Memorial Sloan-Kettering Cancer Center, Pathology
PerkinElmer Life and Analytical Sciences
Weill Medical College of Cornell University
Ortho Clinical Diagnostics Inc. of Johnson and Johnson
The Tbilisi Independent University of Adjara, Tbilisi, Georgia
Pierce Biotechnology, Inc.
Molecular Discovery Systems, Ventana Medical Systems, Inc.
Clinical Microarrays
MWG Biotech
Columbia Genome Center
Abbott Bioresearch Center
Schleicher & Schuell, BioScience, Inc.
Iobion Informatics
ILSbio
High Throughput Genomics
University of Athens and IIBEAA, Athens, Greece
Lynx Therapeutics, Inc.
Abbott Laboratories
Pfizer Global Research & Development
Protometrix, Inc.
University of Michigan Medical School
Memorial Sloan-Kettering Cancer Center, Hematological Oncology
Metrigenix
AstraZeneca Pharmaceuticals
Psychiatric Genomics, Inc.
National Cancer Institute at Frederick, SAIC
The Mount Sinai Hospital
Harvard Institutes of Medicine, Beth Israel Deaconess Medical
Center
Yale University
Matrix Technologies Corp.
National Institute of Health
Industrial Technology Research Institute,
Taiwan 31040, R.O.C.
Ventana Medical Systems, Inc.
US Genomics, Inc.
The Rockefeller University
Morgan & Finnegan, L.L.P.
J.P. Morgan Partners, LLC
Testa, Hurwitz & Thibeault
Press
New York Times
Nature News Service, Nature Publishing Group
BioArray News
Bio-IT World
Wall Street Journal
GenomeWeb LLC
Cambridge University Press
Genome Technology
Crain’s New York Business
 |